Johnson & Johnson acquires Orthotaxy for robotic-assisted orthopedic surgery solution
Johnson & Johnson Medical Devices Companies' orthopedics business, Depuy Synthes, has acquired French private surgical technology company, Orthotaxy, and its robotic-assisted surgery solution for total and partial knee replacement in development. The purchase will bolster Johnson & Johnson's orthopedic surgery platform, which is cost effective and efficient in various care paradigms. The sale was completed through the French affiliate Apsis SAS, and financials were not disclosed.
Foundation and Pfizer partner to develop tumor companion diagnostics for CGP assay
Foundation Medicine Inc. has struck up a partnership with Pfizer Inc. to develop and eventually market companion diagnostics (Cdx) for its comprehensive genomic profiling (CGP) assay, Foundationone Cdx. FDA-approved Foundationone Cdx provides genomic profiles and incorporates additional diagnostic information on solid tumors. The test detects alterations to EGFR, ALK, BRAF, ERBB2, KRAS, NRAS and BRCA1/2 genes.
Med-tech venture investment calls for creativity
SAN FRANCISCO While med-tech investment hit a low point about five to 10 years ago, venture firms are once again interested in the channel, though investments have taken on a different look than previously, according to a panel at the Redefining Early Stage Investment (RESI) meeting.